MiR-150 blunts cardiac dysfunction in mice with cardiomyocyte loss of β(1)-adrenergic receptor/β-arrestin signaling and controls a unique transcriptome.
MiR-150 blunts cardiac dysfunction in mice with cardiomyocyte loss of β(1)-adrenergic receptor/β-arrestin signaling and controls a unique transcriptome.
复制标题
DOI:
10.1038/s41420-022-01295-9
复制
发表时间:
2022-12-30
影响因子:
7
通讯作者:
Kim, Il-man
中科院分区:
文献类型:
--
作者:
Moukette, Bruno;Kawaguchi, Satoshi;Sepulveda, Marisa N.;Hayasaka, Taiki;Aonuma, Tatsuya;Liangpunsakul, Suthat;Yang, Lei;Dharmakumar, Rohan;Conway, Simon J.;Kim, Il-man
The β1-adrenergic receptor (β1AR) is found primarily in hearts (mainly in cardiomyocytes [CMs]) and β-arrestin-mediated β1AR signaling elicits cardioprotection through CM survival. We showed that microRNA-150 (miR-150) is upregulated by β-arrestin-mediated β1AR signaling and that CM miR-150 inhibits maladaptive remodeling post-myocardial infarction. Here, we investigate whether miR-150 rescues cardiac dysfunction in mice bearing CM-specific abrogation of β-arrestin-mediated β1AR signaling. Using CM-specific transgenic (TG) mice expressing a mutant β1AR (G protein-coupled receptor kinase [GRK]–β1AR that exhibits impairment in β-arrestin-mediated β1AR signaling), we first generate a novel double TG mouse line overexpressing miR-150. We demonstrate that miR-150 is sufficient to improve cardiac dysfunction in CM-specific GRK–β1AR TG mice following chronic catecholamine stimulation. Our genome-wide circular RNA, long noncoding RNA (lncRNA), and mRNA profiling analyses unveil a subset of cardiac ncRNAs and genes as heretofore unrecognized mechanisms for beneficial actions of β1AR/β-arrestin signaling or miR-150. We further show that lncRNA Gm41664 and GDAP1L1 are direct novel upstream and downstream regulators of miR-150. Lastly, CM protective actions of miR-150 are attributed to repressing pro-apoptotic GDAP1L1 and are mitigated by pro-apoptotic Gm41664. Our findings support the idea that miR-150 contributes significantly to β1AR/β-arrestin-mediated cardioprotection by regulating unique ncRNA and gene signatures in CMs.
登录
查看更多内容
DOI:
10.1161/circheartfailure.121.008686
发表时间:
2022-04
期刊:
Circulation. Heart failure
影响因子:
--
作者:
Aonuma T;Moukette B;Kawaguchi S;Barupala NP;Sepúlveda MN;Frick K;Tang Y;Guglin M;Raman SV;Cai C;Liangpunsakul S;Nakagawa S;Kim IM
通讯作者:
Kim IM
DOI:
10.1016/j.omtn.2017.06.005
发表时间:
2017-09-15
期刊:
Molecular therapy. Nucleic acids
影响因子:
--
作者:
Chakraborty C;Sharma AR;Sharma G;Doss CGP;Lee SS
通讯作者:
Lee SS
影响因子:
5.6
作者:
Alalaiwe A;Chen CY;Chang ZY;Sung JT;Chuang SY;Fang JY
通讯作者:
Fang JY
影响因子:
--
作者:
Devaux, Yvan;Vausort, Melanie;Squire, Iain B.
通讯作者:
Squire, Iain B.
影响因子:
11.1
作者:
Hsiao J;Yuan TY;Tsai MS;Lu CY;Lin YC;Lee ML;Lin SW;Chang FC;Liu Pimentel H;Olive C;Coito C;Shen G;Young M;Thorne T;Lawrence M;Magistri M;Faghihi MA;Khorkova O;Wahlestedt C
通讯作者:
Wahlestedt C